HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 2,085: | Line 2,085: | ||
| | | | ||
| | | | ||
|- | |||
|Disease (5th Edition) | |||
|Page Type | |||
|Author (5th Edition) (Note: please indicate trainees in parenthesis) | |||
|Date Assigned to Author (5th Edition) | |||
|Target Completion Date (5th Edition) | |||
|Content Status (5th Edition) (Pending or Complete) | |||
|Date Completed by Author (5th Edition) | |||
|Associate Editor | |||
|Date of Last Editor Review (5th Edition) | |||
|Notes (5th Edition) | |||
|Correlated Prior Disease Name (4th Edition) | |||
|Correlated Prior Author (4th Edition) | |||
|Prior Content Status (4th Edition) (Pending or Complete) | |||
|Prior Date of Last Editor Review (4th Edition) | |||
|Prior Notes (4th Edition) | |||
|- | |- | ||
|CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) | ||
| Line 2,179: | Line 2,195: | ||
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS | |[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS | ||
|3/17/24 | |3/17/24 | ||
| | |6/30/24 | ||
|Pending | |||
| ||SK|| || | | ||SK|| || | ||
|T-cell Large Granular Lymphocytic Leukemia | |T-cell Large Granular Lymphocytic Leukemia | ||
| Line 2,189: | Line 2,206: | ||
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS | |[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS | ||
|3/17/24 | |3/17/24 | ||
| | |6/30/24 | ||
|Pending | |||
| ||SK|| || | | ||SK|| || | ||
|Chronic Lymphoproliferative Disorder of NK Cells | |Chronic Lymphoproliferative Disorder of NK Cells | ||
| Line 2,307: | Line 2,325: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease|| | |[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD | ||
| | |3/20/24 | ||
| || || ||SK|| || | |||
|Enteropathy-Associated T-cell Lymphoma | |Enteropathy-Associated T-cell Lymphoma | ||
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | |*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | ||
| Line 2,315: | Line 2,334: | ||
| | | | ||
|- | |- | ||
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease|| | |[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD | ||
| | |3/20/24 | ||
| || || ||SK|| || | |||
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma | |Monomorphic Epitheliotropic Intestinal T-cell Lymphoma | ||
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | |Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | ||
| Line 2,333: | Line 2,353: | ||
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Michelle Don, MD, MS | |[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Michelle Don, MD, MS | ||
|3/19/24 | |3/19/24 | ||
| | |6/30/24 | ||
|Pending | |||
| ||SK|| || | | ||SK|| || | ||
|Hepatosplenic T-cell Lymphoma | |Hepatosplenic T-cell Lymphoma | ||